Literature DB >> 3021816

Salivary antibodies as a means of detecting human T cell lymphotropic virus type III/lymphadenopathy-associated virus infection.

D W Archibald, L I Zon, J E Groopman, J S Allan, M F McLane, M E Essex.   

Abstract

Of 45 individuals seropositive for human T cell lymphotropic virus type III/lymphadenopathy-associated virus, 45 were found to have detectable salivary antibodies to viral antigens by a radioimmunoprecipitation assay. The results also showed that a Western blot assay for salivary antibodies may be possible. The feasibility of a diagnostic test for human T cell lymphotropic virus type III/lymphadenopathy-associated virus not requiring venipuncture is discussed.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3021816      PMCID： PMC269050          DOI： 10.1128/jcm.24.5.873-875.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route.

Authors:  J C Perkins; D N Tucker; H L Knope; R P Wenzel; R B Hornick; A Z Kapikian; R M Chanock
Journal:  Am J Epidemiol       Date:  1969-10       Impact factor: 4.897

Review 3.  NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations.

Authors:  A S Fauci; A M Macher; D L Longo; H C Lane; A H Rook; H Masur; E P Gelmann
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

4.  The acquired immune deficiency syndrome. The ever-broadening clinical spectrum.

Authors:  A S Fauci
Journal:  JAMA       Date:  1983-05-06       Impact factor: 56.272

5.  Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Authors:  M G Sarngadharan; M Popovic; L Bruch; J Schüpbach; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

6.  Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS.

Authors:  D W Archibald; L Zon; J E Groopman; M F McLane; M Essex
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS.

Authors:  M Essex; M F McLane; T H Lee; L Falk; C W Howe; J I Mullins; C Cabradilla; D P Francis
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

9.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728
View more
  10 in total

1.  Detection of salivary antibodies in cats infected with feline immunodeficiency virus.

Authors:  A Poli; C Giannelli; M Pistello; L Zaccaro; D Pieracci; M Bendinelli; G Malvaldi
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

2.  Detection of antibodies to human immunodeficiency virus type 1 in whole blood and saliva by using a passive hemagglutination test.

Authors:  M B Vasudevachari; K Uffelman; P F Pierce; H C Lane; N P Salzman
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

3.  Saliva as a diagnostic fluid.

Authors:  D Malamud
Journal:  BMJ       Date:  1992-07-25

Review 4.  Detection of human immunodeficiency virus antibodies in oral fluids.

Authors:  R L Hodinka; T Nagashunmugam; D Malamud
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

5.  Detection of antibodies to human immunodeficiency virus type 1 in oral fluids: a large-scale evaluation of immunoassay performance.

Authors:  T C Granade; S K Phillips; B Parekh; P Gomez; W Kitson-Piggott; H Oleander; B Mahabir; W Charles; S Lee-Thomas
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

Review 6.  Detecting viruses by using salivary diagnostics.

Authors:  Paul L A M Corstjens; William R Abrams; Daniel Malamud
Journal:  J Am Dent Assoc       Date:  2012-10       Impact factor: 3.634

7.  Importance of collection methods and stability of oral fluid samples for hepatitis B surface antigen detection.

Authors:  Letícia de Paula Scalioni; Helena Medina Cruz; Vanessa Salete de Paula; Jaqueline Corrêia Oliveira; Renata Tourinho Dos Santos; Ana Rita Coimbra Motta-Castro; Paula Guerra Murat; Cristiane Alves Villela-Nogueira; Lia Laura Lewis-Ximenez; Elisabeth Lampe; Livia Melo Villar
Journal:  J Clin Lab Anal       Date:  2013-02-25       Impact factor: 2.352

8.  Detection of specific antibodies in gingival crevicular transudate by enzyme-linked immunosorbent assay for diagnosis of human immunodeficiency virus type 1 infection.

Authors:  L E Soto-Ramírez; L Hernández-Gómez; J Sifuentes-Osornio; G Barriga-Angulo; D Duarte de Lima; M López-Portillo; G M Ruiz-Palacios
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

9.  Oral fluid as a specimen for detection and confirmation of antibodies to human immunodeficiency virus type 1.

Authors:  T C Granade; S K Phillips; B Parekh; C P Pau; J R George
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

Review 10.  Saliva and viral infections.

Authors:  Paul L A M Corstjens; William R Abrams; Daniel Malamud
Journal:  Periodontol 2000       Date:  2016-02       Impact factor: 7.589
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.